ArticleJournal for immunotherapy of cancer2024

HDAC inhibitor SAHA enhances antitumor immunity via the HDAC1/JAK1/FGL1 axis in lung adenocarcinoma.

Tingting Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.